232 related articles for article (PubMed ID: 25393479)
1. Neuritin can normalize neural deficits of Alzheimer's disease.
An K; Jung JH; Jeong AY; Kim HG; Jung SY; Lee K; Kim HJ; Kim SJ; Jeong TY; Son Y; Kim HS; Kim JH
Cell Death Dis; 2014 Nov; 5(11):e1523. PubMed ID: 25393479
[TBL] [Abstract][Full Text] [Related]
2. Neuritin attenuates cognitive function impairments in tg2576 mouse model of Alzheimer's disease.
Choi Y; Lee K; Ryu J; Kim HG; Jeong AY; Woo RS; Lee JH; Hyun JW; Hahn S; Kim JH; Kim HS
PLoS One; 2014; 9(8):e104121. PubMed ID: 25101829
[TBL] [Abstract][Full Text] [Related]
3. L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer's disease mouse model and cultured hippocampal neurons.
Huang L; Lan J; Tang J; Kang Y; Feng X; Wu L; Peng Y
Mol Neurobiol; 2021 Mar; 58(3):1260-1274. PubMed ID: 33146400
[TBL] [Abstract][Full Text] [Related]
4. Synaptic modification by L-theanine, a natural constituent in green tea, rescues the impairment of hippocampal long-term potentiation and memory in AD mice.
Zhu G; Yang S; Xie Z; Wan X
Neuropharmacology; 2018 Aug; 138():331-340. PubMed ID: 29944861
[TBL] [Abstract][Full Text] [Related]
5. Age-related synaptic dysfunction in Tg2576 mice starts as a failure in early long-term potentiation which develops into a full abolishment of late long-term potentiation.
Fernández-Fernández D; Dorner-Ciossek C; Kroker KS; Rosenbrock H
J Neurosci Res; 2016 Mar; 94(3):266-81. PubMed ID: 26629777
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons.
Zolezzi JM; Lindsay CB; Serrano FG; Ureta RC; Theoduloz C; Schmeda-Hirschmann G; Inestrosa NC
J Alzheimers Dis; 2018; 63(2):705-723. PubMed ID: 29660932
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of the Hippocampal POMC/MC4R Circuit Alleviates Synaptic Plasticity Impairment in an Alzheimer's Disease Model.
Shen Y; Tian M; Zheng Y; Gong F; Fu AKY; Ip NY
Cell Rep; 2016 Nov; 17(7):1819-1831. PubMed ID: 27829153
[TBL] [Abstract][Full Text] [Related]
8. Effects of the neurotrophic agent T-817MA on oligomeric amyloid-β-induced deficits in long-term potentiation in the hippocampal CA1 subfield.
Takamura Y; Ono K; Matsumoto J; Yamada M; Nishijo H
Neurobiol Aging; 2014 Mar; 35(3):532-6. PubMed ID: 24112791
[TBL] [Abstract][Full Text] [Related]
9. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
[TBL] [Abstract][Full Text] [Related]
10. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
Faivre E; Hölscher C
J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
[TBL] [Abstract][Full Text] [Related]
11. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II.
Watson JB; Khorasani H; Persson A; Huang KP; Huang FL; O'Dell TJ
J Neurosci Res; 2002 Nov; 70(3):298-308. PubMed ID: 12391589
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer's disease.
Koppensteiner P; Trinchese F; Fà M; Puzzo D; Gulisano W; Yan S; Poussin A; Liu S; Orozco I; Dale E; Teich AF; Palmeri A; Ninan I; Boehm S; Arancio O
Sci Rep; 2016 Sep; 6():32553. PubMed ID: 27581852
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number.
Xu S; Liu G; Bao X; Wu J; Li S; Zheng B; Anwyl R; Wang Q
J Alzheimers Dis; 2014; 39(2):239-51. PubMed ID: 24150104
[TBL] [Abstract][Full Text] [Related]
15. Calcium signaling, excitability, and synaptic plasticity defects in a mouse model of Alzheimer's disease.
Zhang H; Liu J; Sun S; Pchitskaya E; Popugaeva E; Bezprozvanny I
J Alzheimers Dis; 2015; 45(2):561-80. PubMed ID: 25589721
[TBL] [Abstract][Full Text] [Related]
16. SUN11602 has basic fibroblast growth factor-like activity and attenuates neuronal damage and cognitive deficits in a rat model of Alzheimer's disease induced by amyloid β and excitatory amino acids.
Ogino R; Murayama N; Noshita T; Takemoto N; Toba T; Oka T; Narii N; Yoshida S; Ueno N; Inoue T
Brain Res; 2014 Oct; 1585():159-66. PubMed ID: 25130662
[TBL] [Abstract][Full Text] [Related]
17. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
Jing W; Guo F; Cheng L; Zhang JF; Qi JS
Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
[TBL] [Abstract][Full Text] [Related]
18. Synaptic plasticity in animal models of early Alzheimer's disease.
Rowan MJ; Klyubin I; Cullen WK; Anwyl R
Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):821-8. PubMed ID: 12740129
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity.
Chen J; Li S; Sun W; Li J
PLoS One; 2015; 10(4):e0123864. PubMed ID: 25875370
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol reestablishes long-term potentiation in a mouse model of Alzheimer's disease.
Arrieta-Cruz I; Wang J; Pavlides C; Pasinetti GM
J Alzheimers Dis; 2010; 21(2):649-54. PubMed ID: 20571219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
